NCT04164199 2026-03-16Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced MalignanciesBeOne MedicinesPhase 3 Enrolling by invitation430 enrolled
NCT07384377 2026-02-03JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and IrinotecanShanghai JMT-Bio Inc.Phase 3 Not yet recruiting123 enrolled